Abstract
We explored the effects of daylight saving time (DST) clock changes on sleep duration in a large accelerometer dataset. Our sample included UK Biobank participants (n= 11,780; aged 43-78) with accelerometer data for one or more days during the two weeks surrounding the Spring and Autumn DST transitions from October 2013 and November 2015. Between-individual t-tests compared sleep duration on the Sunday (midnight to midnight) of the clock changes to the Sunday before and the Sunday after. We also compared sleep duration on all other days (Monday-Saturday) before and after the clock changes. In Spring, mean sleep duration was 65 minutes lower on the Sunday of the clock changes than the Sunday before (95%CI -72 to -58 minutes) and 61 minutes lower than the Sunday after (95%CI -69 to -53). In Autumn, the mean sleep duration on the Sunday of the clock changes was 33 minutes higher than the Sunday before (95% CI 27 to 39 minutes) and 38 minutes higher than the Sunday after (95% CI 32 to 43 minutes). There was some evidence of catch-up sleep after both transitions, with sleep duration a little higher on the Monday - Friday than before, although this was less pronounced in Autumn. Future research should use large datasets with longer periods of accelerometer wear to capture sleep duration before and after the transition in the same individuals, and examine other aspects of sleep such as circadian misalignment, sleep fragmentation or daytime napping.
Competing Interest Statement
The authors have declared no competing interest.
Funding Statement
This research was funded in whole or in part by the Wellcome Trust [grant number 226909/Z/23/Z]. For open access, the author has applied a CC BY public copyright licence to any Author Accepted Manuscript version arising from this submission. M.A.dL is funded by the Wellcome Trust [grant number 226909/Z/23/Z]. M.A.dL, R.C.R, K.T., K.B. and C.Y.S. work in a unit that receives support from the University of Bristol and the UK Medical Research Council [grant numbers MC_UU_00032/1, MC_UU_00032/02, MC/UU/00032/3, MC/UU/00032/4]. N.M.D is supported by the Norwegian Research Council [grant number 295989] and the UCL Division of Psychiatry (https://www.ucl.ac.uk/psychiatry/division-psychiatry). RCR is supported by Cancer Research UK (grant number C18281/A29019) and NIHR Oxford Health Biomedical Research Centre (grant number: NIHR203316).
Author Declarations
I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.
Yes
The details of the IRB/oversight body that provided approval or exemption for the research described are given below:
UK Biobank is approved by the National Health Service National Research Ethics Service (ref. 11/NW/0382; UK Biobank application number 88626). Informed consent was obtained from all individual participants included in the study.
I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.
Yes
I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).
Yes
I have followed all appropriate research reporting guidelines, such as any relevant EQUATOR Network research reporting checklist(s) and other pertinent material, if applicable.
Yes
Data availability statement
The UK Biobank dataset used to conduct the research in this paper is available via application directly to the UK Biobank. Applications are assessed to meet the required criteria for access, including legal and ethical standards. More information regarding data access can be found at https://www.ukbiobank.ac.uk/enable-your-research. Full code for all analyses is available at https://github.com/MeldeLange/dst_accel
